Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemiaMio Yamamoto‐Sugitani, Masafumi Taniwaki, Tsutomu Kobayashi et al.|Proceedings of the National Academy of Sciences|2011Cited by 100
8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemiaYoshiaki Chinen, Masafumi Taniwaki, Natsumi Sakamoto et al.|Journal of Hematology & Oncology|2014Cited by 48
Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpressionNana Sasaki, Masafumi Taniwaki, Junya Kuroda et al.|Experimental Hematology|2011Cited by 33
Epigenetic repression of miR‐375 is the dominant mechanism for constitutive activation of the <scp>PDPK</scp>1/<scp>RPS</scp>6<scp>KA</scp>3 signalling axis in multiple myelomaShotaro Tatekawa, Junya Kuroda, Yoshiaki Chinen et al.|British Journal of Haematology|2017Cited by 26
Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering <scp>miR</scp>‐106a‐5p and <scp>miR</scp>‐146a‐5p in multiple myelomaKentaro Mizuhara, Junya Kuroda, Yuji Shimura et al.|British Journal of Haematology|2023Cited by 20